At Rescription, we see firsthand how Pharmacy Benefit Managers (PBMs) affect the healthcare landscape—and it’s clear that reform is long overdue. Like Rep. Buddy Carter (R-GA), Sen. James Lankford (R-OK), Rep. Nanette Barragan (D-CA), and other bipartisan lawmakers who have recently rallied for PBM reform, we believe that addressing the inefficiencies and profit-driven practices of PBMs is critical for creating a more transparent, affordable, and patient-centered healthcare system.
What’s at Stake
PBMs were originally designed to manage prescription drug benefits, negotiate better pricing, and pass savings to consumers. However, over time, their opaque practices and profit motives have worked against these goals. PBMs now dictate medication prices at the pharmacy counter, often incentivizing higher costs for their own benefit. They play games with rebates that should reduce patient and employer expenses while creating barriers to care for patients who struggle to access vital medications.
As Rep. Carter aptly pointed out during a recent Capitol Hill press conference, PBMs are decreasing the affordability, accessibility, and quality of healthcare in America. This dysfunction impacts not just patients but also employers, independent pharmacies, and healthcare systems—undermining trust in the entire process.
Rescription’s Role as a Solution
At Rescription, we’ve built an innovative PBM alternative to eliminate these inefficiencies and realign the system with the needs of patients and payers. Our anti-PBM™ model uses radical clarity, advanced technology, and direct partnerships with health systems to guarantee the lowest possible drug prices. Key components of our approach include:
Guaranteed Drug Pricing
Patient-Centered Care
Support for Employers
Why PBM Reform Matters Now
PBM reform is not just a political issue—it’s a human one. The stories of patients denied access to life-saving medications because of PBM practices underscore the urgency of change. As Sen. Lankford said, “We don’t want to tell patients, ‘Wait another two years and maybe we’ll get into it.’” Action is needed now.
Congress has already made significant strides, with bipartisan legislation passed in the House and support from seven congressional committees. However, these reforms must move forward in the lame-duck session to deliver real relief to patients and employers.
Rescription’s Call to Action
We applaud the efforts of lawmakers like Rep. Carter, Sen. Lankford, and Reps. Miller-Meeks, Krishnamoorthi, and Barragan. Their commitment to transparency, fairness, and patient-first principles aligns with our mission at Rescription.
The time to act is now. Congress must prioritize PBM reform to restore fairness and affordability to the prescription drug market. Rescription is proud to be part of the movement to eliminate the middleman, empower patients, and reduce costs for employers.
Together, we can create a healthcare system where patients come first—and PBMs no longer stand in the way.
At Rescription, we remain committed to reshaping the future of pharmacy benefits. To learn more about how our innovative model works, contact us directly to discuss solutions for your organization.